Result For Shiseido's Phase 2 Trial?

C

champpy

Experienced Member
Reaction score
1,118
If successful, i hope they already have a plan in place to deal with customers who will be flying in to have this done. One that involves like satellite clinics that can take our cells and have them shipped to Japan.
Wishful thinking im sure.
 
MrV88

MrV88

Senior Member
My Regimen
Reaction score
1,242
ElTioLaBota said:
Remember that aside all the great inventions the Japanese ppl did they also invented Hentai...
There is a slight chance of shisheido f*****g up
Click to expand...
Hentai...you clearly don't get the concept, they didn't f*** it up, they took it to the next level!
 
dermrafok

dermrafok

Established Member
My Regimen
Reaction score
512
RepliCel CEO Provides 2018 Shareholder Update
With a new Asian partnership and 2017 deliverables met, RepliCel is primed and ready for expansion

In 2018, shareholders should expect to see:

  • The launch of a European multi-centre, phase 2 clinical trial measuring the impact of RCS-01 injections on aging skin.
  • Completion of commercial-grade prototypes for the RCI-02 dermal injector.
  • Filing of a CE-mark application for our dermal injector seeking the regulatory marketing approval needed to commercially launch the device in Europe and Hong Kong.
  • Preparations for launching the device in Hong Kong by licensing partner, YOFOTO (China) Health Industry Co. Ltd.
  • Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia.
  • Data from the research program at UBC identifying different genetic marker expression profiles of various cell populations in the hair follicle with an aim of potentially improving cell selection, manufacturing, and clinical outcomes.
  • The launch of tendon repair (RCT-01) and skin rejuvenation (RCS-01) clinical trial activity in Hong Kong and/or Mainland China funded by YOFOTO.
  • The launch of planned product development projects with various partners intended to add significant value to our programs.
  • A meeting with the FDA reviewing one or more of our programs.
  • Business development activity which may well lead to the execution of other commercial partnerships.

Not bad.
 
K

kawnshawn

Established Member
Reaction score
413
dermrafok said:
RepliCel CEO Provides 2018 Shareholder Update
With a new Asian partnership and 2017 deliverables met, RepliCel is primed and ready for expansion

In 2018, shareholders should expect to see:

  • The launch of a European multi-centre, phase 2 clinical trial measuring the impact of RCS-01 injections on aging skin.
  • Completion of commercial-grade prototypes for the RCI-02 dermal injector.
  • Filing of a CE-mark application for our dermal injector seeking the regulatory marketing approval needed to commercially launch the device in Europe and Hong Kong.
  • Preparations for launching the device in Hong Kong by licensing partner, YOFOTO (China) Health Industry Co. Ltd.
  • Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia.
  • Data from the research program at UBC identifying different genetic marker expression profiles of various cell populations in the hair follicle with an aim of potentially improving cell selection, manufacturing, and clinical outcomes.
  • The launch of tendon repair (RCT-01) and skin rejuvenation (RCS-01) clinical trial activity in Hong Kong and/or Mainland China funded by YOFOTO.
  • The launch of planned product development projects with various partners intended to add significant value to our programs.
  • A meeting with the FDA reviewing one or more of our programs.
  • Business development activity which may well lead to the execution of other commercial partnerships.

Not bad.
Click to expand...
Hopefully they have their company update in the next few months for 2018 that should give some more info.
 
R

razzmatazz91

Senior Member
My Regimen
Reaction score
850
dermrafok said:
RepliCel CEO Provides 2018 Shareholder Update
With a new Asian partnership and 2017 deliverables met, RepliCel is primed and ready for expansion

In 2018, shareholders should expect to see:

  • The launch of a European multi-centre, phase 2 clinical trial measuring the impact of RCS-01 injections on aging skin.
  • Completion of commercial-grade prototypes for the RCI-02 dermal injector.
  • Filing of a CE-mark application for our dermal injector seeking the regulatory marketing approval needed to commercially launch the device in Europe and Hong Kong.
  • Preparations for launching the device in Hong Kong by licensing partner, YOFOTO (China) Health Industry Co. Ltd.
  • Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia.
  • Data from the research program at UBC identifying different genetic marker expression profiles of various cell populations in the hair follicle with an aim of potentially improving cell selection, manufacturing, and clinical outcomes.
  • The launch of tendon repair (RCT-01) and skin rejuvenation (RCS-01) clinical trial activity in Hong Kong and/or Mainland China funded by YOFOTO.
  • The launch of planned product development projects with various partners intended to add significant value to our programs.
  • A meeting with the FDA reviewing one or more of our programs.
  • Business development activity which may well lead to the execution of other commercial partnerships.

Not bad.
Click to expand...

You've been doing your research. + respect.

What's with this though: "Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia."

I thought this was supposed to be in Q2. Does this mean that the Phase 1 data came out in 2017?
Wasn't around here before late 2017 myself, so let me know.
 
br1

br1

Senior Member
Reaction score
2,161
razzmatazz91 said:
You've been doing your research. + respect.

What's with this though: "Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia."

I thought this was supposed to be in Q2. Does this mean that the Phase 1 data came out in 2017?
Wasn't around here before late 2017 myself, so let me know.
Click to expand...

Well. Phase 1 results were released by Replicel early 2017. It showed treatment was safe. And, even though trial was designed for safety only, some efficacy was also observed.

As per their agreement, Shiseido used this Phase1 results, and jumped straight into Phase 2 . Shiseido will release results from this phase2 Q2 this year.
 
dermrafok

dermrafok

Established Member
My Regimen
Reaction score
512
razzmatazz91 said:
You've been doing your research. + respect.

What's with this though: "Data from the clinical research being funded by Shiseido in Japan measuring the benefit of RCH-01 injections in men and women suffering from hair loss due to androgenic alopecia."

I thought this was supposed to be in Q2. Does this mean that the Phase 1 data came out in 2017?
Wasn't around here before late 2017 myself, so let me know.
Click to expand...
@br1 Is right.
 
  • Like
Reactions: br1
R

razzmatazz91

Senior Member
My Regimen
Reaction score
850
br1 said:
Well. Phase 1 results were released by Replicel early 2017. It showed treatment was safe. And, even though trial was designed for safety only, some efficacy was also observed.

As per their agreement, Shiseido used this Phase1 results, and jumped straight into Phase 2 . Shiseido will release results from this phase2 Q2 this year.
Click to expand...

"In 2018, shareholders should expect to see"

So this means it's slated for 2018.
Thanks for the clarification up @br1
 
  • Like
Reactions: br1
d3nt3dsh0v3l

d3nt3dsh0v3l

Experienced Member
My Regimen
Reaction score
1,709
Endmymisery said:
Hentai is art
Click to expand...

Yes.
YoshitoshiRainyDayTanukiscrotum.jpg.838x0_q80.jpg

mizuki_shigeru_tanuki_big_balls.png

V2jp3Es.gif

Tanuki%2B%25281%2529.gif
 
You must log in or register to reply here.
Community platform by XenForo® © 2010-2023 XenForo Ltd.
Top